Browse Category

Stock Updates News 17 November 2025 - 16 December 2025

IREN Stock (NASDAQ: IREN) News Today, Dec. 15, 2025: Paul Tudor Jones Trims Stake as Analysts Watch the Microsoft AI Cloud Rollout

IREN Stock (NASDAQ: IREN) News Today, Dec. 15, 2025: Paul Tudor Jones Trims Stake as Analysts Watch the Microsoft AI Cloud Rollout

Dec. 15, 2025 — IREN stock is back in the spotlight on Monday as investors weigh a fresh round of “who’s buying and who’s selling” headlines against a much bigger question: can the former bitcoin miner successfully execute one of the
Hycroft Mining (HYMC) Stock News Today: Eric Sprott Adds $5.7M Ahead of Dec. 29 Annual Meeting, Debt-Free Balance Sheet in Focus (Dec. 12, 2025)

Hycroft Mining (HYMC) Stock News Today: Eric Sprott Adds $5.7M Ahead of Dec. 29 Annual Meeting, Debt-Free Balance Sheet in Focus (Dec. 12, 2025)

(SEO): Hycroft Mining Holding Corporation (NASDAQ: HYMC) stock is active on Dec. 12, 2025 after Eric Sprott disclosed new share purchases. Here’s the latest HYMC news, forecasts, and analysis. Published: December 12, 2025Company: Hycroft Mining Holding Corporation (NASDAQ: HYMC) Hycroft
NVIDIA Stock News Today (Dec. 12, 2025): NVDA Holds Near $181 as AI “Bubble” Fears Collide With Blackwell Growth Forecasts

NVIDIA Stock News Today (Dec. 12, 2025): NVDA Holds Near $181 as AI “Bubble” Fears Collide With Blackwell Growth Forecasts

NVIDIA Corporation (NASDAQ: NVDA) is ending the week with investors pulled in two directions: near-term jitters around the pace and profitability of AI infrastructure spending, and longer-term optimism that NVIDIA’s Blackwell-driven product cycle can restart the stock’s momentum in 2026.
Life360 (ASX:360, Nasdaq:LIF) Stock on 8 December 2025: Q3 Beat, Nativo Deal, Sell‑Off and 2026 Forecasts

Life360 (ASX:360, Nasdaq:LIF) Stock on 8 December 2025: Q3 Beat, Nativo Deal, Sell‑Off and 2026 Forecasts

8 December 2025 – Life360, Inc., the family safety and location‑sharing platform behind the Life360 app and Tile trackers, is having another volatile day on the markets despite reporting record third‑quarter results and announcing a major ad‑tech acquisition. On the
Stellantis (STLA) Stock Jumps on UBS Upgrade and US Hiring Spree – Key News, Forecasts and Risks on December 3, 2025

Stellantis (STLA) Stock Jumps on UBS Upgrade and US Hiring Spree – Key News, Forecasts and Risks on December 3, 2025

Stellantis N.V. (NYSE: STLA) is back in the market spotlight. On December 3, 2025, the automaker’s shares are rallying in Europe and the US after a high‑profile analyst upgrade, fresh details on its American growth push, and a controversial class‑action
Constellation Energy (CEG) Stock Today, November 23, 2025: $1 Billion DOE Loan, AI Data Center Demand and What It Means for Investors

Constellation Energy (CEG) Stock Today, November 23, 2025: $1 Billion DOE Loan, AI Data Center Demand and What It Means for Investors

Key takeaways All figures and commentary are as of Sunday, November 23, 2025. U.S. markets are closed today; prices refer to Friday’s close unless otherwise noted. 1. Constellation Energy stock on November 23, 2025 With markets closed for the weekend,
Ondas Holdings (ONDS) Stock News Today, November 22, 2025: S‑8 Filing, Institutional Moves and Drone‑Defense Deals After a 7% Jump

Ondas Holdings (ONDS) Stock News Today, November 22, 2025: S‑8 Filing, Institutional Moves and Drone‑Defense Deals After a 7% Jump

Ondas Holdings Inc. (NASDAQ: ONDS) heads into the weekend still riding one of 2025’s most explosive rallies in defense and autonomous systems — and today’s tape brings a fresh mix of regulatory filings, institutional moves and valuation debate for investors
Merck (MRK) Jumps as Oral PCSK9 Data Power Momentum; New Keytruda Diagnostic Cleared — What’s Moving the Stock Today (Nov. 12, 2025)

Merck (MRK) Stock Today, Nov 18, 2025: Shares Jump on Winrevair Phase 2 Win as Cidara Deal Builds Flu Portfolio

November 18, 2025 — Merck & Co. (NYSE: MRK) is trading higher today after the company reported new mid‑stage data for its cardiopulmonary medicine Winrevair (sotatercept‑csrk), fueling optimism about growth beyond Keytruda and adding momentum to last week’s acquisition of
Go toTop